应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
FTSV Forty Seven Inc.
停牌 04-21 06:58:26 EDT
95.51
+0.00
0.00%
最高
95.51
最低
95.51
成交量
0.00
今开
95.51
昨收
95.51
日振幅
0.00%
总市值
45.99亿
流通市值
34.57亿
总股本
4,816万
成交额
0.00
换手率
0.00%
流通股本
3,619万
市净率
14.47
ROE
-38.84%
每股收益
-2.40
52周最高
95.52
52周最低
5.53
市盈率
-39.71
股息
0.00
股息收益率
0.00
ROA
-22.45%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称：
Forty Seven Inc.
所属市场：
NASDAQ
上市日期：
2018-06-28
主营业务：
Forty Seven, Inc.于2014年在特拉华州注册成立。该公司是一家临床阶段免疫肿瘤学公司，致力于开发新型检查点疗法，以激活巨噬细胞对抗癌症。该公司基于阻断CD47（一种在癌细胞上过度表达的关键信号分子）使肿瘤易受巨噬细胞影响的见解创立了Forty Seven。通过利用巨噬细胞，该公司相信他们的首要候选产品5F9作为单一疗法或与市售癌症疗法联合给药，可以改变癌症治疗。5F9在6个1b/2期临床试验中表现出了有希望的活性，在这些试验中，他们已经治疗了190例复发性或难治性肿瘤患者，其中包括实体瘤或血液肿瘤。该公司拥有全球所有产品候选人的权利。
发行价格：
16.00
{"stockData":{"symbol":"FTSV","market":"US","secType":"STK","nameCN":"Forty Seven Inc.","latestPrice":95.51,"timestamp":1586203200000,"preClose":95.51,"halted":3,"volume":0,"delay":0,"floatShares":36190929,"shares":48156251,"eps":-2.404899,"marketStatus":"停牌","change":0,"latestTime":"04-21 06:58:25 EDT","open":95.51,"high":95.51,"low":95.51,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.404899,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745242200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1530158400000,"exchange":"NASDAQ","adjPreClose":95.51,"volumeRatio":0},"requestUrl":"/m/hq/s/FTSV","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.fortyseveninc.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Forty Seven, Inc.于2014年在特拉华州注册成立。该公司是一家临床阶段免疫肿瘤学公司，致力于开发新型检查点疗法，以激活巨噬细胞对抗癌症。该公司基于阻断CD47（一种在癌细胞上过度表达的关键信号分子）使肿瘤易受巨噬细胞影响的见解创立了Forty Seven。通过利用巨噬细胞，该公司相信他们的首要候选产品5F9作为单一疗法或与市售癌症疗法联合给药，可以改变癌症治疗。5F9在6个1b/2期临床试验中表现出了有希望的活性，在这些试验中，他们已经治疗了190例复发性或难治性肿瘤患者，其中包括实体瘤或血液肿瘤。该公司拥有全球所有产品候选人的权利。","exchange":"NASDAQ","name":"Forty Seven Inc.","nameEN":"Forty Seven Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Forty Seven Inc.(FTSV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Forty Seven Inc.(FTSV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Forty Seven Inc.,FTSV,Forty Seven Inc.股票,Forty Seven Inc.股票老虎,Forty Seven Inc.股票老虎国际,Forty Seven Inc.行情,Forty Seven Inc.股票行情,Forty Seven Inc.股价,Forty Seven Inc.股市,Forty Seven Inc.股票价格,Forty Seven Inc.股票交易,Forty Seven Inc.股票购买,Forty Seven Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Forty Seven Inc.(FTSV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Forty Seven Inc.(FTSV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}